First, a cheap steroid known as dexamethasone was the first drug shown to reduce death in Covid-19 patients, and the trials proving its effectiveness came from the U.K., with Oxford University playing a prominent role. In one sample, the drug reduced deaths among a vulnerable group by one-third (it is less effective for milder cases). Dexamethasone is now a part of treatment regimens around the world, and even poor countries can afford it.
It is fair to call this achievement a home run, or at least a triple (or must I say, “a six”?). And while Spain also had a role in proving the beneficial use of this drug, the U.K. clinched the path-breaking research.
The world is also in the midst of a race to find a safe and effective vaccine against Covid-19. And so far the leading contender comes from the U.K. Results published on Monday indicate that the vaccine generated an immune response in a group of about 1,000 patients. To develop this vaccine, the British-Swedish drug company AstraZeneca has been working with Oxford, and the company has inked a major deal for widespread distribution to poorer countries.